Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2004, Vol. 104, No. 8, pp. 2523-2531.
Prepublished online as a Blood First Edition Paper on June 29, 2004; DOI 10.1182/blood-2003-12-4251.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-12-4251v1
104/8/2523    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinha-Datta, U.
Right arrow Articles by Nicot, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinha-Datta, U.
Right arrow Articles by Nicot, C.
Related Collections
Right arrow Neoplasia
Right arrow Signal Transduction
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

NEOPLASIA

Transcriptional activation of hTERT through the NF-{kappa}B pathway in HTLV-I–transformed cells

Uma Sinha-Datta, Izumi Horikawa, Eriko Michishita, Abhik Datta, Janitzia C. Sigler-Nicot, Megan Brown, Mirdad Kazanji, J. Carl Barrett, and Christophe Nicot

From the Department of Microbiology, Immunology, and Molecular Genetics, University of Kansas Medical Center, Kansas City, KS; the Department of Obstetrics/Gynecology, Division of Reproductive Biology and Vaccine Research Peptide and Protein Engineering Laboratory, Ohio State University, Columbus, OH; and the Laboratory of Biosystems and Cancer, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

In immortal cells, the existence of a mechanism for the maintenance of telomere length is critical. In most cases this is achieved by the reactivation of telomerase, a cellular reverse transcriptase that prevents telomere shortening. Here we report that the telomerase gene (hTERT) promoter is up-regulated during transmission of human T-cell lymphotropic virus type-I (HTLV-I) to primary T cells in vitro and in ex vivo adult T-cell leukemia/lymphoma (ATLL) samples, but not asymptomatic carriers. Although Tax impaired induction of human telomerase reverse transcriptase (hTERT) mRNA in response to mitogenic stimulation, transduction of Tax into primary lymphocytes was sufficient to activate and maintain telomerase expression and telomere length when cultured in the absence of any exogenous stimulation. Transient transfection assays revealed that Tax stimulates the hTERT promoter through the nuclear factor {kappa}B (NF-{kappa}B) pathway. Consistently, Tax mutants inactive for NF-{kappa}B activation could not activate the hTERT or sustain telomere length in transduced primary lymphocytes. Analysis of the hTERT promoter occupancy in vivo using chromatin immunoprecipitation assays suggested that an increased binding of c-Myc and Sp1 is involved in the NF-{kappa}B–mediated activation of the hTERT promoter. This study establishes the role of Tax in regulation of telomerase expression, which may cooperate with other functions of Tax to promote HTLV-I–associated adult T-cell leukemia.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
M. Bellon and C. Nicot
Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells
Blood, October 1, 2008; 112(7): 2946 - 2955.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Bellon and C. Nicot
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
J Natl Cancer Inst, January 16, 2008; 100(2): 98 - 108.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Yang, R. Zhang, I. Horikawa, K. Fujita, Y. Afshar, A. Kokko, P. Laiho, L. A. Aaltonen, and C. C. Harris
Functional Diversity of Human Protection of Telomeres 1 Isoforms in Telomere Protection and Cellular Senescence
Cancer Res., December 15, 2007; 67(24): 11677 - 11686.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G P Taylor
Molecular aspects of HTLV-I infection and adult T-cell leukaemia/lymphoma
J. Clin. Pathol., December 1, 2007; 60(12): 1392 - 1396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
U. Sinha-Datta, A. Datta, S. Ghorbel, M. D. Dodon, and C. Nicot
Human T-cell Lymphotrophic Virus Type I Rex and p30 Interactions Govern the Switch between Virus Latency and Replication
J. Biol. Chem., May 11, 2007; 282(19): 14608 - 14615.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Ghorbel, U. Sinha-Datta, M. Dundr, M. Brown, G. Franchini, and C. Nicot
Human T-cell Leukemia Virus Type I p30 Nuclear/Nucleolar Retention Is Mediated through Interactions with RNA and a Constituent of the 60 S Ribosomal Subunit
J. Biol. Chem., December 1, 2006; 281(48): 37150 - 37158.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Datta, M. Bellon, U. Sinha-Datta, A. Bazarbachi, Y. Lepelletier, D. Canioni, T. A. Waldmann, O. Hermine, and C. Nicot
Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence
Blood, August 1, 2006; 108(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Braun, G. Carvalho, A. Coquelle, M.-C. Vozenin, P. Lepelley, F. Hirsch, J.-J. Kiladjian, V. Ribrag, P. Fenaux, and G. Kroemer
NF-{kappa}B constitutes a potential therapeutic target in high-risk myelodysplastic syndrome
Blood, February 1, 2006; 107(3): 1156 - 1165.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
E. Michishita, J. Y. Park, J. M. Burneskis, J. C. Barrett, and I. Horikawa
Evolutionarily Conserved and Nonconserved Cellular Localizations and Functions of Human SIRT Proteins
Mol. Biol. Cell, October 1, 2005; 16(10): 4623 - 4635.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
Y. Matsumura-Arioka, K. Ohtani, T. Hara, R. Iwanaga, and M. Nakamura
Identification of two distinct elements mediating activation of telomerase (hTERT) gene expression in association with cell growth in human T cells
Int. Immunol., February 1, 2005; 17(2): 207 - 215.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020